TDRL-551 is a novel and potent replication protein A (RPA) inhibitor (IC50=18 µM) with potential anticancer activity.TDRL-551 inhibits RPA-DNA interaction and enhances the efficacy of platinum-based chemotherapy for lung and ovarian cancer.
Molecular Weight:
591.83
Purity:
98.09%
CAS Number:
[1644626-43-6]
Formula:
C25H23ClIN3O4
Target:
Others|||DNA/RNA Synthesis
T28935
* VAT and and shipping costs not included. Errors and price changes excepted